「to」の検索結果
420件：341～345件目を表示
-
Publications | Research & Development | SENJU Pharmaceutica
tients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding Study Yuichi Hori1, Tomoyuki Wada2, Kazunori Omatsu2, on behalf of the SJP-0132 clinical study investigators 1: Departme...
http://www.senju.co.jp/english/rd/thesis/ -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
e East UAE Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmaceticals Factory BRONUCK Iraq Brand Name Marketing Authorisation Holder JP Brand Name BROFIX Jamjoom Pharmacetic...
https://www.senju.co.jp/english/global/world.html -
ミケランLA点眼液 添付文書 2022年3月改訂 TD75X2B17
－0.65 ［－1.66, 0.34］ ミケラン点眼液1％ 75 －5.67±3.30 眼圧下降度：平均値±標準偏差、差：平均値 （症例数は点眼60日後の 症例数を示す。 ） ITT：Intent-to-treat 副作用発現頻度は、本剤1％で74例中2例 （2.7％） 、ミケラン 点眼液1％で75例中1例 （1.3％） であった。副作用は、本剤1％ では点状角膜炎及び浮動性めまいが各1例 （1...
https://www.senju.co.jp/system/files/product_other_file/2022-03/MKLA_17_20220330_0.pdf -
Company Profile | About Senju | SENJU Pharmaceutical
512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi...
https://www.senju.co.jp/english/about/outline.html -
Company Profile | About Senju | SENJU Pharmaceutical
512 FAX：+81-6-6226-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi...
http://www.senju.co.jp/english/about/outline.html